We report two THC2 patients misdiagnosed with myelodysplasia and treated with chemotherapy.
2
Cytopenia at day 30 was not significantly associated with later diagnosis of myelodysplasia.
3
Bone marrow biopsy done 3 months prior showed no significant myelodysplasia or lymphoid aggregates.
4
Results in myelodysplasia and aplastic anemia have been less encouraging.
5
However, there are very limited data on the development of hemophagocytosis or myelodysplasia in these patients.
6
Twelve patients suffered chronic toxicity, including six who suffered lung toxicity and two who developed secondary myelodysplasia.
7
Outcomes of patients with persistent high-risk leukemia or myelodysplasia prior to allogeneic hematopoietic cell transplantation are dismal.
8
In 19 patients the abnormal clone was at least temporarily ablated, while in one patient the congenital myelodysplasia persisted.
9
Their bone marrow examination revealed a wide spectrum of pathology varying from bone marrow hypoplasia, hemophagocytosis to myelodysplasia with ring sideroblasts.
10
Finally, our results may suggest a possible broader role of FOXP1 in the pathogenesis and progression of myelodysplasia and acute myeloid leukemia.
11
But we don't believe it shows myelodysplasia or aplastic anemia. This sort of uncertainty didn't sit well with him, as I recall.
12
FOXP1 was also found activated in other patients with myelodysplasia and acute myeloid leukemia, showing that it is an important, recurrent event.
13
Hydronephrosis has been reported to be present at birth in 6 to 28 per cent of newborns with myelodysplasia.
14
Here we review the participation of zinc finger transcription factor GATA-2 in regulating normal hematopoietic stem and progenitor cell functionality, myelodysplasia and myeloid leukemia.
15
We report two THC2 patients misdiagnosed with myelodysplasia and treated with chemotherapy.
16
Cytopenia at day 30 was not significantly associated with later diagnosis of myelodysplasia.